HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins

HIV-1 can incite activation of chemokine receptors, inflammatory mediators, and glutamate receptor-mediated excitotoxicity. The mechanisms associated with such immune activation can disrupt neuronal and glial functions. HIV-associated neurocognitive disorder (HAND) is being observed since the beginn...

Full description

Saved in:
Bibliographic Details
Main Authors: Sushama Jadhav, Vijay Nema
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/1267041
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567696543186944
author Sushama Jadhav
Vijay Nema
author_facet Sushama Jadhav
Vijay Nema
author_sort Sushama Jadhav
collection DOAJ
description HIV-1 can incite activation of chemokine receptors, inflammatory mediators, and glutamate receptor-mediated excitotoxicity. The mechanisms associated with such immune activation can disrupt neuronal and glial functions. HIV-associated neurocognitive disorder (HAND) is being observed since the beginning of the AIDS epidemic due to a change in the functional integrity of cells from the central nervous system (CNS). Even with the presence of antiretroviral therapy, there is a decline in the functioning of the brain especially movement skills, noticeable swings in mood, and routine performance activities. Under the umbrella of HAND, various symptomatic and asymptomatic conditions are categorized and are on a rise despite the use of newer antiretroviral agents. Due to the use of long-lasting antiretroviral agents, this deadly disease is becoming a manageable chronic condition with the occurrence of asymptomatic neurocognitive impairment (ANI), symptomatic mild neurocognitive disorder, or HIV-associated dementia. In-depth research in the pathogenesis of HIV has focused on various mechanisms involved in neuronal dysfunction and associated toxicities ultimately showcasing the involvement of various pathways. Increasing evidence-based studies have emphasized a need to focus and explore the specific pathways in inflammation-associated neurodegenerative disorders. In the current review, we have highlighted the association of various HIV proteins and neuronal cells with their involvement in various pathways responsible for the development of neurotoxicity.
format Article
id doaj-art-f2430260877c4979b03d117145d655c7
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-f2430260877c4979b03d117145d655c72025-02-03T01:00:47ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/12670411267041HIV-Associated Neurotoxicity: The Interplay of Host and Viral ProteinsSushama Jadhav0Vijay Nema1Division of Molecular Biology, National AIDS Research Institute (ICMR-NARI), 73, G Block, MIDC, Bhosari, Post Box No. 1895, Pune, 411026 Maharashtra, IndiaDivision of Molecular Biology, National AIDS Research Institute (ICMR-NARI), 73, G Block, MIDC, Bhosari, Post Box No. 1895, Pune, 411026 Maharashtra, IndiaHIV-1 can incite activation of chemokine receptors, inflammatory mediators, and glutamate receptor-mediated excitotoxicity. The mechanisms associated with such immune activation can disrupt neuronal and glial functions. HIV-associated neurocognitive disorder (HAND) is being observed since the beginning of the AIDS epidemic due to a change in the functional integrity of cells from the central nervous system (CNS). Even with the presence of antiretroviral therapy, there is a decline in the functioning of the brain especially movement skills, noticeable swings in mood, and routine performance activities. Under the umbrella of HAND, various symptomatic and asymptomatic conditions are categorized and are on a rise despite the use of newer antiretroviral agents. Due to the use of long-lasting antiretroviral agents, this deadly disease is becoming a manageable chronic condition with the occurrence of asymptomatic neurocognitive impairment (ANI), symptomatic mild neurocognitive disorder, or HIV-associated dementia. In-depth research in the pathogenesis of HIV has focused on various mechanisms involved in neuronal dysfunction and associated toxicities ultimately showcasing the involvement of various pathways. Increasing evidence-based studies have emphasized a need to focus and explore the specific pathways in inflammation-associated neurodegenerative disorders. In the current review, we have highlighted the association of various HIV proteins and neuronal cells with their involvement in various pathways responsible for the development of neurotoxicity.http://dx.doi.org/10.1155/2021/1267041
spellingShingle Sushama Jadhav
Vijay Nema
HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
Mediators of Inflammation
title HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
title_full HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
title_fullStr HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
title_full_unstemmed HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
title_short HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
title_sort hiv associated neurotoxicity the interplay of host and viral proteins
url http://dx.doi.org/10.1155/2021/1267041
work_keys_str_mv AT sushamajadhav hivassociatedneurotoxicitytheinterplayofhostandviralproteins
AT vijaynema hivassociatedneurotoxicitytheinterplayofhostandviralproteins